T-Tucker did I miss something? You said: IMLFF making money and saving lives! Winner in both arenas.
From the InsiderFinancial article mentioned here in a later post:
Financial Performance
A perusal of the firm’s statement of comprehensive income reveals that operating expenses have nearly doubled between 2016 and 2017. With no revenues disclosed within the period, the company had a net loss of $0.34 million in the year.
The firm has very low leverage with a significant portion of its coming from its equity. It also has very high liquidity of 18.8, a likely result of the new funds from the private placement done recently.
Conclusion
The results of IMLFF’s recent capital raise proves that the market has enough confidence in its ability to progress.
I’ll agree with the conclusion that the market has the confidence to support the current share price, but I’m not aware of any revenue being generated yet. I do believe we are cautiously pricing in the future value, but I’m watching it closely because all it takes to put this back in the pennies is any bad press. Like: patent not issued. I’m confident it will be if the attorneys did there research exhaustively. When InMed gets the patent the share price will likely move sharply north to reflect coming revenue from sales. I don’t think anyone wants to miss that run. Until then I realize the value of my money is in your hands. As long as we collectively maintain confidence in our InMed. Its a bit uneasy for me right now. I think that’s why we hover around the $1.70ish level. I’m not prepared to pay more until InMed has more to report on.
Good luck to us all.
News 
Market Data 
Discover 
